Jianfeng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianfeng Zhang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Chengqi Guan
Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, China
4 shared publications- Weifeng Ding
Department of Laboratory Medicine; Department of Gastrointestinal Surgery, Affiliated Hospital of Nantong University, Medical school of Nantong University, Nantong 226001, Jiangsu Province, China
4 shared publications Cuihua Lu
Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, China
3 shared publicationsZhenbiao Mao
Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, China
3 shared publicationsChenxi Wu
2 shared publicationsJingxin Ye
Department of Laboratory Medicine; Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
2 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
The efficacy and safety of endoscopic ultrasound selective variceal devascularization for the treatment of esophagogastric varices: a retrospective cohort study
- 23 July 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessThe efficacy and safety of endoscopic ultrasound selective variceal devascularization for the treatment of esophagogastric varices: a retrospective cohort study
- Open Access
- 9 July 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-12
M6A-METTL3-dependent nuclear PANC754/PSPC1/H3K4me1 repression complex regulate immune evasive LGALS7 signal to enhance immunotherapy against colorectal cancer
Non-coding RNAs (ncRNAs) have important regulatory functions similar to traditional oncogenes or tumor suppressor genes. Our previous research found a novel pan-cancer downexpressed ncRNA, PANC754. However, its function and underlying mechanism remain obscure in colorectal cancer (CRC). In this study, in vitro and in vivo experiments were performed to determine the function of PANC754. Loss and gain of function experiments, molecular docking experiments, and bioinformatic analysis were utilized to visualize its pathway. Co-culture system was leveraged to explore its effect on synergetic immune checkpoint blockage against CRC. Through a series of studies, we found that overexpressed PANC754 significantly inhibited cell viability, migration, and metastasis and induced notable apoptosis in CRC. The mechanical research found that PANC754 was the nuclear-located and its expression was regulated by m6A modification via METTL3 enzyme, which bound with its RBP PSPC1, then interacted with H3K4me1 to chromatin-accessible inhibit immune evasive molecule LGALS7 and led to suppress CRC progress. Furthermore, we confirmed that prominent upregulation of the immune checkpoint inhibitory (ICI) capability of anti-NKG2A, monalizumab when it was combined with PANC754 overexpression. Collectively, our study revealed that PANC754 is a tumor-suppressing ncRNA to form an ncRNA/RBP/histone repression complex with m6A-dependence, which can enhance the immune therapeutics effect of ICI, suggesting a promising therapeutic target.
- 9 July 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-12
Open AccessM6A-METTL3-dependent nuclear PANC754/PSPC1/H3K4me1 repression complex regulate immune evasive LGALS7 signal to enhance immunotherapy against colorectal cancer
Non-coding RNAs (ncRNAs) have important regulatory functions similar to traditional oncogenes or tumor suppressor genes. Our previous research found a novel pan-cancer downexpressed ncRNA, PANC754. However, its function and underlying mechanism remain obscure in colorectal cancer (CRC). In this study, in vitro and in vivo experiments were performed to determine the function of PANC754. Loss and gain of function experiments, molecular docking experiments, and bioinformatic analysis were utilized to visualize its pathway. Co-culture system was leveraged to explore its effect on synergetic immune checkpoint blockage against CRC. Through a series of studies, we found that overexpressed PANC754 significantly inhibited cell viability, migration, and metastasis and induced notable apoptosis in CRC. The mechanical research found that PANC754 was the nuclear-located and its expression was regulated by m6A modification via METTL3 enzyme, which bound with its RBP PSPC1, then interacted with H3K4me1 to chromatin-accessible inhibit immune evasive molecule LGALS7 and led to suppress CRC progress. Furthermore, we confirmed that prominent upregulation of the immune checkpoint inhibitory (ICI) capability of anti-NKG2A, monalizumab when it was combined with PANC754 overexpression. Collectively, our study revealed that PANC754 is a tumor-suppressing ncRNA to form an ncRNA/RBP/histone repression complex with m6A-dependence, which can enhance the immune therapeutics effect of ICI, suggesting a promising therapeutic target.
- Open Access
- 13 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (24) , e42615
An unusually acute abdominal pain: A case report
Rationale: Acute abdominal pain is a common clinical symptom. Its etiology is complex and intricate. This is a case of small intestinal obstruction caused by bezoar combined with diabetes ketoacidosis, which leads to abdominal pain. The obstruction was caused by bezoars, which is rare in clinical practice, and worth summarizing and learning. Patient concerns: We reported a case of a 58-year-old female who was admitted to the hospital due to “upper abdominal pain for 3 days”. Diagnoses: Fasting blood glucose was 21 mmol/L, urinary ketone body 3+, pondus hydrogenii (pH) 7.309, actual and standard bicarbonate decreased, and abdominal enhanced computed tomography showed a rounded low-density shadow with sharp edges and well-defined borders in the lumen of the bowel on the left side of the abdomen, with a size of 6 cm, and no significant enhancement within the lesion. Interventions: Including hypoglycemic treatment, correction of acid–base imbalance and electrolyte disorders, and removal of gastric stones through laparoscopy, etc. Outcomes: This abdominal pain was caused by a small intestinal obstruction caused by bezoar combined with diabetes ketoacidosis. The patient was discharged successfully and remained symptom-free during follow-up. Lessons: There are many causes of acute abdominal pain. In clinical practice, we should comprehensively consider and diagnose the causes of abdominal pain based on the patient’s current medical history, past medical history, physical examination, and auxiliary examinations. We must be alert to rare and multiple causes that can jointly cause abdominal pain, and promptly deal with different causes.
- 13 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (24) , e42615
Open AccessAn unusually acute abdominal pain: A case report
Rationale: Acute abdominal pain is a common clinical symptom. Its etiology is complex and intricate. This is a case of small intestinal obstruction caused by bezoar combined with diabetes ketoacidosis, which leads to abdominal pain. The obstruction was caused by bezoars, which is rare in clinical practice, and worth summarizing and learning. Patient concerns: We reported a case of a 58-year-old female who was admitted to the hospital due to “upper abdominal pain for 3 days”. Diagnoses: Fasting blood glucose was 21 mmol/L, urinary ketone body 3+, pondus hydrogenii (pH) 7.309, actual and standard bicarbonate decreased, and abdominal enhanced computed tomography showed a rounded low-density shadow with sharp edges and well-defined borders in the lumen of the bowel on the left side of the abdomen, with a size of 6 cm, and no significant enhancement within the lesion. Interventions: Including hypoglycemic treatment, correction of acid–base imbalance and electrolyte disorders, and removal of gastric stones through laparoscopy, etc. Outcomes: This abdominal pain was caused by a small intestinal obstruction caused by bezoar combined with diabetes ketoacidosis. The patient was discharged successfully and remained symptom-free during follow-up. Lessons: There are many causes of acute abdominal pain. In clinical practice, we should comprehensively consider and diagnose the causes of abdominal pain based on the patient’s current medical history, past medical history, physical examination, and auxiliary examinations. We must be alert to rare and multiple causes that can jointly cause abdominal pain, and promptly deal with different causes.
- Open Access
- 16 January 2024
- Published by Open Exploration Publishing in Exploration of Targeted Anti-tumor Therapy
- Vol. 5 (1) , 34-53
DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine
Colorectal cancer (CRC) is a multifaceted disease influenced by the interplay of genetic and environmental factors. The clinical heterogeneity of CRC cannot be attributed exclusively to genetic diversity and environmental exposures, and epigenetic markers, especially DNA methylation, play a critical role as key molecular markers of cancer. This review compiles a comprehensive body of evidence underscoring the significant involvement of DNA methylation modifications in the pathogenesis of CRC. Moreover, this review explores the potential utility of DNA methylation in cancer diagnosis, prognostics, assessment of disease activity, and prediction of drug responses. Recognizing the impact of DNA methylation will enhance the ability to identify distinct CRC subtypes, paving the way for personalized treatment strategies and advancing precision medicine in the management of CRC.
- 16 January 2024
- Published by Open Exploration Publishing in Exploration of Targeted Anti-tumor Therapy
- Vol. 5 (1) , 34-53
Open AccessDNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine
Colorectal cancer (CRC) is a multifaceted disease influenced by the interplay of genetic and environmental factors. The clinical heterogeneity of CRC cannot be attributed exclusively to genetic diversity and environmental exposures, and epigenetic markers, especially DNA methylation, play a critical role as key molecular markers of cancer. This review compiles a comprehensive body of evidence underscoring the significant involvement of DNA methylation modifications in the pathogenesis of CRC. Moreover, this review explores the potential utility of DNA methylation in cancer diagnosis, prognostics, assessment of disease activity, and prediction of drug responses. Recognizing the impact of DNA methylation will enhance the ability to identify distinct CRC subtypes, paving the way for personalized treatment strategies and advancing precision medicine in the management of CRC.
- Open Access
- 22 May 2023
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 26 (1) , 1-9
Macroscopic on‑site quality evaluation of biopsy specimens to improve the diagnostic accuracy of endoscopic ultrasound‑guided fine needle aspiration using a 22‑gauge needle for solid lesions: A single‑center retrospective study
The present study aimed to evaluate the clinical value of macroscopic on‑site evaluation (MOSE) of solid masses by endoscopic ultrasound (EUS)‑guided fine needle aspiration (FNA) using a standard 22‑gauge needle and to explore the cut‑off length of macroscopic visible core (MVC) required to obtain an accurate histopathological diagnosis. In total, 119 patients who satisfied the inclusion and exclusion criteria and underwent EUS‑FNA were divided into conventional FNA and FNA combined with MOSE groups. In the MOSE group, the presence of MVC was examined and its total length measured, after which the pathological results of FNA were compared with the final diagnosis. The diagnostic sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of FNA in the two groups were calculated and the effect of MOSE on the FNA result was analyzed. The MOSE group had a higher diagnostic sensitivity (75.0% vs. 89.8%; P=0.038) and accuracy (74.5% vs. 90.6%; P=0.026). MVC was observed in 98.4% (63/64) of patients in the MOSE group. The median length of MVC was 15 mm. The optimal cut‑off length of MVC for obtaining an accurate histological diagnosis was 13 mm, with a sensitivity of 90.2%. No statistically significant significance was observed in the specificity, PPV and NPV between the groups. Thus, MOSE helps to improve the diagnostic ability of FNA for solid masses and may be a useful alternative to assess the adequacy of puncture specimens in units where rapid on‑site evaluation cannot be performed.
- 22 May 2023
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 26 (1) , 1-9
Open AccessMacroscopic on‑site quality evaluation of biopsy specimens to improve the diagnostic accuracy of endoscopic ultrasound‑guided fine needle aspiration using a 22‑gauge needle for solid lesions: A single‑center retrospective study
The present study aimed to evaluate the clinical value of macroscopic on‑site evaluation (MOSE) of solid masses by endoscopic ultrasound (EUS)‑guided fine needle aspiration (FNA) using a standard 22‑gauge needle and to explore the cut‑off length of macroscopic visible core (MVC) required to obtain an accurate histopathological diagnosis. In total, 119 patients who satisfied the inclusion and exclusion criteria and underwent EUS‑FNA were divided into conventional FNA and FNA combined with MOSE groups. In the MOSE group, the presence of MVC was examined and its total length measured, after which the pathological results of FNA were compared with the final diagnosis. The diagnostic sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of FNA in the two groups were calculated and the effect of MOSE on the FNA result was analyzed. The MOSE group had a higher diagnostic sensitivity (75.0% vs. 89.8%; P=0.038) and accuracy (74.5% vs. 90.6%; P=0.026). MVC was observed in 98.4% (63/64) of patients in the MOSE group. The median length of MVC was 15 mm. The optimal cut‑off length of MVC for obtaining an accurate histological diagnosis was 13 mm, with a sensitivity of 90.2%. No statistically significant significance was observed in the specificity, PPV and NPV between the groups. Thus, MOSE helps to improve the diagnostic ability of FNA for solid masses and may be a useful alternative to assess the adequacy of puncture specimens in units where rapid on‑site evaluation cannot be performed.